Correlation Between Unity Biotechnology and Kronos Bio
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Kronos Bio, you can compare the effects of market volatilities on Unity Biotechnology and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Kronos Bio.
Diversification Opportunities for Unity Biotechnology and Kronos Bio
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Unity and Kronos is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Kronos Bio go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Kronos Bio
Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Kronos Bio. In addition to that, Unity Biotechnology is 1.03 times more volatile than Kronos Bio. It trades about -0.04 of its total potential returns per unit of risk. Kronos Bio is currently generating about -0.01 per unit of volatility. If you would invest 234.00 in Kronos Bio on September 26, 2024 and sell it today you would lose (139.00) from holding Kronos Bio or give up 59.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Kronos Bio
Performance |
| Timeline |
| Unity Biotechnology |
| Kronos Bio |
Unity Biotechnology and Kronos Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Kronos Bio
The main advantage of trading using opposite Unity Biotechnology and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.| Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
| Kronos Bio vs. Fate Therapeutics | Kronos Bio vs. Caribou Biosciences | Kronos Bio vs. Karyopharm Therapeutics | Kronos Bio vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |